As melanoma progresses, they undergo a cadherin subtype switch in which they downregulate E-cadherin and upregulate N-cadherin, thereby escaping keratinocyte-mediated controls while promoting migration and survival10–12. This evidence concerns the gene CDH2 and melanoma.